Rapid nucleus-scale reorganization of chromatin in neurons enables transcriptional adaptation for memory consolidation

PLoS One. 2021 May 5;16(5):e0244038. doi: 10.1371/journal.pone.0244038. eCollection 2021.

Abstract

The interphase nucleus is functionally organized in active and repressed territories defining the transcriptional status of the cell. However, it remains poorly understood how the nuclear architecture of neurons adapts in response to behaviorally relevant stimuli that trigger fast alterations in gene expression patterns. Imaging of fluorescently tagged nucleosomes revealed that pharmacological manipulation of neuronal activity in vitro and auditory cued fear conditioning in vivo induce nucleus-scale restructuring of chromatin within minutes. Furthermore, the acquisition of auditory fear memory is impaired after infusion of a drug into auditory cortex which blocks chromatin reorganization in vitro. We propose that active chromatin movements at the nucleus scale act together with local gene-specific modifications to enable transcriptional adaptations at fast time scales. Introducing a transgenic mouse line for photolabeling of histones, we extend the realm of systems available for imaging of chromatin dynamics to living animals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological / genetics*
  • Animals
  • Cell Nucleus / metabolism*
  • Chromatin / genetics*
  • Memory Consolidation / physiology*
  • Mice
  • Neurons / cytology*
  • Transcription, Genetic*

Substances

  • Chromatin

Grants and funding

WH and FG were supported by the European Community’s Seventh Framework Programme (FP/2007-2013) / ERC grant agreement no. 311701. MP and SR were supported by the Austrian Science Fund (FWF): P21930-B09. AS, HJL and SR were supported by the Deutsche Forschungsgemeinschaft (DFG) collaborative research center CRC1080 (TP A01 and TP C05). Support by the Core Facility Microscopy of the IMB in Mainz is gratefully acknowledged. RR is a graduate student of the International PhD programme coordinated by the Institute of Molecular Biology Mainz. The Research Institute of Molecular Pathology (IMP) is supported by Boehringer Ingelheim and the Austrian Research Promotion Agency (FFG). The Vienna BioCenter Core Facilities (VBCF) Preclinical Phenotyping Facility acknowledges funding from the Austrian Federal Ministry of Education, Science & Research; and the City of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.